263 articles
A major study of 600,000 veterans finds GLP-1 weight loss drugs like Ozempic may reduce addiction risk and opioid overdose by up to 40%. New hope for addiction treatment.
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Jaff, Vice President and Chief Medical Officer, Peripheral Interventions at Boston Scientific and Dr. Learn more on Health Professional Radio.
Trial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, di...
Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s...
Lee, MD, Cherng Family Director's Chair, Center for Integrative Oncology at City of Hope, one of the largest cancer research and treatment organizations...
KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical, part of the Meeting Protocol Worldwide family...
Andrea Furlan, MD, PhD, Associate Professor in the Department of Medicine at the University of Toronto and a Staff Physician and Senior Scientist at the...
Christopher Flowers, M.D., Department of Lymphoma - Myeloma, Division of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD A...
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...